Dipeptidyl peptidase-IV inhibits glioma cell growth independent of its enzymatic activity
Language English Country Netherlands Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
22306301
DOI
10.1016/j.biocel.2012.01.011
PII: S1357-2725(12)00015-5
Knihovny.cz E-resources
- MeSH
- Cell Adhesion MeSH
- Cell Cycle MeSH
- Dipeptidases genetics metabolism MeSH
- Dipeptidyl Peptidase 4 genetics metabolism MeSH
- Dipeptidyl-Peptidases and Tripeptidyl-Peptidases genetics metabolism MeSH
- Glioma enzymology genetics MeSH
- Immunomagnetic Separation MeSH
- Humans MeSH
- Mutation MeSH
- Mice MeSH
- Tumor Cells, Cultured MeSH
- Cell Movement MeSH
- Primary Cell Culture MeSH
- Cell Proliferation MeSH
- Gene Expression Regulation, Neoplastic * MeSH
- Signal Transduction genetics MeSH
- Gene Expression Profiling MeSH
- Transfection MeSH
- Xenograft Model Antitumor Assays MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Dipeptidases MeSH
- Dipeptidyl Peptidase 4 MeSH
- Dipeptidyl-Peptidases and Tripeptidyl-Peptidases MeSH
- DPP4 protein, human MeSH Browser
- DPP8 protein, human MeSH Browser
- DPP9 protein, human MeSH Browser
Malignant gliomas exhibit abnormal expression of proteolytic enzymes that may participate in the uncontrolled cell proliferation and aberrant interactions with the brain extracellular matrix. The multifunctional membrane bound serine aminopeptidase dipeptidyl peptidase (DPP)-IV has been linked to the development and progression of several malignancies, possibly both through the enzymatic and nonenzymatic mechanisms. In this report we demonstrate the expression of DPP-IV and homologous proteases fibroblast activation protein, DPP8 and DPP9 in primary cell cultures derived from high-grade gliomas, and show that the DPP-IV-like enzymatic activity is negatively associated with their in vitro growth. More importantly, the DPP-IV positive subpopulation isolated from the primary cell cultures using immunomagnetic separation exhibited slower proliferation. Forced expression of the wild as well as the enzymatically inactive mutant DPP-IV in glioma cell lines resulted in their reduced growth, migration and adhesion in vitro, as well as suppressed glioma growth in an orthotopic xenotransplantation mouse model. Microarray analysis of glioma cells with forced DPP-IV expression revealed differential expression of several candidate genes not linked to the tumor suppressive effects of DPP-IV in previous studies. Gene set enrichment analysis of the differentially expressed genes showed overrepresentation of gene ontology terms associated with cell proliferation, cell adhesion and migration. In conclusion, our data show that DPP-IV may interfere with several aspects of the malignant phenotype of glioma cells in great part independent of its enzymatic activity.
References provided by Crossref.org
Microtubule-associated NAV3 regulates invasive phenotypes in glioblastoma cells
Does DPP-IV Inhibition Offer New Avenues for Therapeutic Intervention in Malignant Disease?
Fibroblast Activation Protein Expressing Mesenchymal Cells Promote Glioblastoma Angiogenesis
Effect of cancer-associated fibroblasts on the migration of glioma cells in vitro